The German Biobank Node (GBN), which is part of BBMRI-ERIC, asked more than 330 “potential biobank users” at university hospitals about their attitudes towards collaborating with biobanks. Here, Dr. Cornelia Specht, managing director of the GBN, tells us about the survey results and conclusions.
King’s Health Partners Cancer Biobank at Guy’s and St Thomas’ and Focus Games have developed a digital biobanking game. Here, Dr. Cheryl Gillett, Head of Biobanking at King’s College London, tells us more.
In this post we hear from John Meredith, Head of Education and Outreach at Understanding Animal Research to find out more about human samples and animal research.
Finding out what makes researchers tick Here at the UKCRC TDCC we want to help researchers use human samples in their research. In order to do this we are undertaking some research of our own! In 2016 the UKCRC TDCC launched the UK’s first cross disease sample register to help researchers find existing samples. Since then the resource has been developed in response to feedback we have received from the… Read More »Finding out what makes researchers tick
Spotlight on: Gautam Mehta Job title: Honorary Consultant and Senior Lecturer, UCL Research Project: Gautam is exploring new ways to treat patients with liver failure and alcohol-related liver disease. Liver disease is the third commonest cause of preventable death in the UK and rates are rising rapidly, therefore new treatments are urgently needed. Gautam’s research involves sequencing RNA (part of the genetic code of cells) from human liver and immune cells… Read More »Spotlight on: Gautam Mehta
Spotlight on: Ana Rio-Machin Job title: Postdoctoral Researcher at Barts Cancer Institute (BCI), Queen Mary University of London Research Project: Ana researches the genetic alterations (mutations) that are inherited in families who have leukaemia without a known cause, within a Bloodwise funded programme; ‘Acute Myeloid Leukaemia (AML) familial cases, where two or more affected individuals are found in the same family, are rare but represent a high-risk group of patients… Read More »Spotlight on: Ana Rio-Machin